Alzamend Neuro, Inc. (ALZN): Price and Financial Metrics
ALZN Price/Volume Stats
| Current price | $1.31 | 52-week high | $15.06 |
| Prev. close | $1.40 | 52-week low | $1.25 |
| Day low | $1.27 | Volume | 118,400 |
| Day high | $1.40 | Avg. volume | 512,449 |
| 50-day MA | $1.62 | Dividend yield | N/A |
| 200-day MA | $4.99 | Market Cap | 5.10M |
ALZN Stock Price Chart Interactive Chart >
Alzamend Neuro, Inc. (ALZN) Company Bio
Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
ALZN Price Returns
| 1-mo | -22.94% |
| 3-mo | -57.47% |
| 6-mo | -78.17% |
| 1-year | -87.52% |
| 3-year | -99.54% |
| 5-year | N/A |
| YTD | -85.28% |
| 2023 | -89.50% |
| 2022 | -70.27% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...